A team of researchers from the Keck School of Medicine of USC and California Institute of Technology (Caltech) have developed a potential new way to measure a person's stroke risk that is ...

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection, today announced the publication of ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

A shoebox-sized optical device reads glucose directly through the skin in seconds, offering a promising step toward truly noninvasive, point-of-care glucose monitoring. Pipeline for the development of ...

The DLP4500NIR is the first DLP device optimized for use with near infrared (NIR) light. Together, the DLP4500NIR and the DLP NIRscan evaluation module suit transmittance and reflective spectroscopy ...

A study that looks into the potential of future wearables to non-invasively measure blood glucose has brought promising results. Nature published the study, which involved the participation of 50 ...

Researchers developed a wearable device that can be used for non-invasive stroke risk assessment. The device uses speckle contrast optical spectroscopy to track changes in blood flow and volume in the ...

Data published in the Journal of the American Board of Family Medicine shows that DermaSensor’s elastic scattering spectroscopy device improves primary care clinicians’ ability to assess skin lesions ...